Literature DB >> 10507774

The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma.

H Saito1, S Tsujitani, S Oka, A Kondo, M Ikeguchi, M Maeta, N Kaibara.   

Abstract

The expression of thymidine phosphorylase (TP) and the density of microvessel in advanced gastric carcinoma were examined by immunohistochemistry to evaluate the significance of TP. The expression of TP was negative in 72 cases, positive in 54. The microvessel density correlated with the expression of TP. In total cases, patients with TP-positive tumours survived longer than those with TP-negative tumours. In patients treated with fluorouracil derivatives (FUs), the expression of TP significantly correlated with favourable prognosis and with unfavourable prognosis in those not treated with FUs. The patients with TP-positive tumours, the prognosis of patients treated with FUs was significantly better than that of those not treated with FUs. In patients with TP-positive tumours, treatment with FUs and lymph node metastasis were independent prognostic factors according to the Cox proportional hazards model. Depth of invasion and lymph node metastasis were independent prognostic factors in patients with TP-negative tumours. The determination of the expression of TP might be useful for predicting the efficacy of post-operative chemotherapy using FUs to prevent recurrence in advanced gastric carcinoma patients who undergo curative gastrectomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507774      PMCID: PMC2362934          DOI: 10.1038/sj.bjc.6690719

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.

Authors:  Y Maehara; A Watanabe; Y Kakeji; H Baba; S Kohnoe; K Sugimachi
Journal:  Am J Surg       Date:  1990-09       Impact factor: 2.565

2.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

3.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

4.  Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

Authors:  A Kono; Y Hara; S Sugata; Y Karube; Y Matsushima; H Ishitsuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-01       Impact factor: 1.645

Review 5.  Concepts for treatment of micrometastases developed in murine systems.

Authors:  F M Schabel
Journal:  AJR Am J Roentgenol       Date:  1976-03       Impact factor: 3.959

6.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.

Authors:  D Zagzag; D C Miller; Y Sato; D B Rifkin; D E Burstein
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

7.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

8.  Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.

Authors:  A Moghaddam; R Bicknell
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

9.  Potential of the histoculture drug-response assay to contribute to cancer patient survival.

Authors:  T Kubota; N Sasano; O Abe; I Nakao; E Kawamura; T Saito; M Endo; K Kimura; H Demura; H Sasano
Journal:  Clin Cancer Res       Date:  1995-12       Impact factor: 12.531

10.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

View more
  11 in total

Review 1.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 2.  Molecular markers for gastric adenocarcinoma: an update.

Authors:  Casandra Anderson; Amar Nijagal; Joseph Kim
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Thymidylate synthase, thymidine phosphorylase, VEGF and p53 protein expression in primary colorectal cancer for predicting response to 5-fluorouracil-based chemotherapy.

Authors:  Myung-Ju Ahn; Jung-Hye Choi; Ho-Suk Oh; Young-Yeul Lee; In-Soon Kim; Il-Young Choi; Kang-Hong Lee; Kang-Won Song; Chan-Kum Park
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

4.  Angiogenesis and lymphangiogenesis of gastric cancer.

Authors:  Yasuhiko Kitadai
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

5.  Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.

Authors:  Hye Sung Won; Myung Ah Lee; Eun-Seon Chung; Dong-Goo Kim; Young Kyoung You; Tae Ho Hong; In-Seok Lee
Journal:  BMC Cancer       Date:  2010-10-19       Impact factor: 4.430

6.  Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.

Authors:  Dong Hua; Zhao-Hui Huang; Yong Mao; Jian-Zhong Deng
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

7.  Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.

Authors:  Tao Ma; Zheng-Gang Zhu; Yu-Bao Ji; Yi Zhang; Ying-Yan Yu; Bing-Ya Liu; Hao-Ran Yin; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

8.  Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase.

Authors:  P Cuq; C Rouquet; A Evrard; J Ciccolini; L Vian; J P Cano
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

9.  A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.

Authors:  G Ranieri; L Grammatica; R Patruno; A F Zito; P Valerio; S Iacobellis; C Gadaleta; G Gasparini; D Ribatti
Journal:  J Cell Mol Med       Date:  2007-03-22       Impact factor: 5.310

10.  Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

Authors:  M de Bruin; T van Capel; K Van der Born; F A Kruyt; M Fukushima; K Hoekman; H M Pinedo; G J Peters
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.